Mumbai, Oct. 7 -- The revenue growth includes contributions from Core Diagnostics, Scientific Pathology (Scientific), Agra and Dr. Ahuja's Pathology & Imaging Center (DAPIC), Dehradun.

The TruHealth Wellness and Specialty segments posted YoY growth of about 25% and 36%, respectively, in Q2FY26.

B2C revenues registered a YoY growth of around 16%, while B2B revenues grew approximately 34% driven by higher contribution of B2B business in core diagnostics.

During the quarter, the company acquired Dr. RS Patil's Ambika Pathology Laboratory, Kolhapur (Ambika Pathology), effective September 18, 2025. This acquisition strengthens the company's leadership position in the Kolhapur region and is strategically aimed at establishing a mini referenc...